Degenerative Diseases
Vasculitis is a common autoimmune condition with the inflammation of the blood vessels; including arteries, veins as well as capillaries. The inflamed blood vessel can be narrowed down obstructing the flow of blood to major organs of the body. In severe forms of Vasculitis, the blood vessel can even be weakened or stretched to the extent that it can cause aneurism.
How can GIOSTAR's Stem Cell Therapy help?
GIOSTAR's Stem Cell Therapy can repopulate the damaged parts of the organ, through their strong paracrine effects and differentiate into lost or damaged cells to restore back the function. These stem cells can regulate the immune system and minimize the impact of autoimmunity. One of the important properties of mesenchymal stem cells is to promote vascularization and vessel formation, which can improve the strength of the blood vessels and also promote synthesis of new vessels.
Thus with our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements in the patients with the Vasculitis, in the symptoms as well as their functional abilities.
Stem cell therapy like any other type of medical procedure have no guarantees and is not promoted as a cure. Reviews and testimonials on this site are personal experiences of our patients. An evaluation from the medical team is required to determine if you are a candidate for stem cell therapy and any personal information provided is for internal and medical use only at GIOSTAR. GIOSTAR hearquarters and research is done in San Diego, California. Adipose Derived Minimally Manipulated Autologous Stem Cell Therapy is regulated by the Federal Drug Administration (FDA) under these guidelines and generally falls under physician's discretion via exception in 21 CFR 1271.15(b) in the United States. Canadian laws state that stem cell therapy is approved only for research. Stem cell therapy at GIOSTAR Mexico is regulated and approved by COFEPRIS and other local authorities and is practiced within the legal limits of Mexico.